Coloplast A/S Competitors
| Ticker | Name | Consensus | Stock Rating | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| PG | Procter & Gamble | Outperform |
12
|
$158.14 | $166.80 | 9.04% | 5 | $372.11B |
| JNJ | Johnson & Johnson | Outperform |
9
|
$147.91 | $174.55 | 14.93% | 3 | $356.43B |
| PFE | Pfizer | Outperform |
2
|
$26.00 | $32.87 | 17.31% | 6 | $147.23B |
| ULVR | Unilever PLC | Hold |
8
|
£38.11 | £50.61 | 30.31% | 12 | £95.37B |
| SAN | Sanofi | Outperform |
16
|
86.89€ | 102.80€ | 24.30% | 9 | 108.49€B |
| BMY | Bristol-Myers Squibb | Hold |
2
|
$48.93 | $58.15 | 12.41% | 10 | $99.17B |
| RKT | Reckitt Benckiser Group | Outperform |
12
|
£41.67 | £66.68 | 37.99% | 12 | £29.43B |
| BEI | Beiersdorf | Outperform |
17
|
135.80€ | 137.41€ | 9.72% | 3 | 30.80€B |
| BAYN | Bayer | Hold |
5
|
26.33€ | 45.15€ | 21.53% | 4 | 25.86€B |
| CLX | Clorox Co-The | Hold |
16
|
$143.55 | $154.18 | 7.98% | 9 | $17.82B |
| SN. | Smith & Nephew | Outperform |
18
|
£9.62 | £16.09 | 70.58% | 10 | £8.39B |
| CTEC | ConvaTec Group PLC | Outperform |
16
|
£2.83 | £3.43 | 40.28% | 6 | £5.46B |
| HYPE3 | Hypera | Outperform |
16
|
R$28.35 | R$45.97 | 45.50% | 3 | R$21.21B |
| PRGO | Perrigo Co PLC | Outperform |
16
|
$30.80 | $44.75 | 29.87% | 0 | $3.70B |
| AXNX | Axonics | Hold |
7
|
$66.95 | $70.15 | 6.05% | 2 | $3.41B |
| IART | Integra LifeSciences Holdings | Hold |
16
|
$28.68 | $46.60 | 51.67% | 4 | $3.02B |
| ORGO | Organogenesis Holdings | Outperform |
10
|
$2.90 | $4.75 | 72.41% | 1 | $468.79M |
| CLGN | CollPlant Biotechnologies | Buy |
7
|
$5.55 | $0.00 | 204.14% | 0 | $65.00M |
| 540468 | KMS Medisurgi | - |
0
|
34.35 | 0.00 | -100.00% | 0 | 113.03M |